Literature DB >> 21659261

Recovery and wellness amidst schizophrenia: definitions, evidence, and the implications for clinical practice.

Paul H Lysaker1, David Roe, Kelly D Buck.   

Abstract

Emerging evidence from longitudinal studies has suggested that many with schizophrenia can meaningfully recover over time. Recovery, though, is not a uniform process but varies from person to person and can involve a range of different experiences including the attainment of psychosocial milestones, the remission of symptoms, and changes in self-experience or personal narrative. To address the issue of recovery from schizophrenia, this article reviews currently evolving definitions of recovery and possible ways to understand recovery as involving both an objective and two subjective dimensions. Emerging operational definitions are explored and then empirical research is reviewed regarding actual rates and forms of recovery. It is concluded that although many with schizophrenia experience significant challenges linked with illness over time, more people than not experience meaningful periods of relative wellness. Implications for how daily practice can reinforce and promote recovery are discussed.

Entities:  

Year:  2010        PMID: 21659261     DOI: 10.1177/1078390309353943

Source DB:  PubMed          Journal:  J Am Psychiatr Nurses Assoc        ISSN: 1078-3903            Impact factor:   2.385


  10 in total

Review 1.  The Relationship Between Clinical and Personal Recovery in Patients With Schizophrenia Spectrum Disorders: A Systematic Review and Meta-analysis.

Authors:  Robin Michael Van Eck; Thijs Jan Burger; Astrid Vellinga; Frederike Schirmbeck; Lieuwe de Haan
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306

2.  Family involvement moderates the relationship between perceived recovery orientation of services and personal narratives among Chinese with schizophrenia in Hong Kong: a 1-year longitudinal investigation.

Authors:  Ben C L Yu; Winnie W S Mak; Floria H N Chio
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-08-14       Impact factor: 4.328

3.  Flourishing With Psychosis: A Prospective Examination on the Interactions Between Clinical, Functional, and Personal Recovery Processes on Well-being Among Individuals with Schizophrenia Spectrum Disorders.

Authors:  Randolph C H Chan; Winnie W S Mak; Floria H N Chio; Alan C Y Tong
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

4.  Personal Recovery and Its Determinants Among People Living With Schizophrenia in China.

Authors:  Yu Yu; Xi Xiao; Min Yang; Xiao-Ping Ge; Tong-Xin Li; Gui Cao; Ying-Jun Liao
Journal:  Front Psychiatry       Date:  2020-12-11       Impact factor: 4.157

5.  Informing DSM-5: biological boundaries between bipolar I disorder, schizoaffective disorder, and schizophrenia.

Authors:  Victoria E Cosgrove; Trisha Suppes
Journal:  BMC Med       Date:  2013-05-14       Impact factor: 8.775

6.  Assessment of functioning in patients with schizophrenia and schizoaffective disorder with the Mini-ICF-APP: a validation study in Italy.

Authors:  Federica Pinna; Andrea Fiorillo; Massimo Tusconi; Beatrice Guiso; Bernardo Carpiniello
Journal:  Int J Ment Health Syst       Date:  2015-10-31

7.  Criteria for symptom remission revisited: a study of patients affected by schizophrenia and schizoaffective disorders.

Authors:  Federica Pinna; Massimo Tusconi; Marta Bosia; Roberto Cavallaro; Bernardo Carpiniello
Journal:  BMC Psychiatry       Date:  2013-09-26       Impact factor: 3.630

8.  Neurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls--first steps in development of a biomarker.

Authors:  Frank H Duffy; Eugene D'Angelo; Alexander Rotenberg; Joseph Gonzalez-Heydrich
Journal:  BMC Med       Date:  2015-11-02       Impact factor: 8.775

9.  Consensus five factor PANSS for evaluation of clinical remission: effects on functioning and cognitive performances.

Authors:  Federica Pinna; Marta Bosia; Roberto Cavallaro; Bernardo Carpiniello
Journal:  Schizophr Res Cogn       Date:  2014-12-08

10.  Factors related to improvement of symptoms, function, and caregiver burden in Chinese patients with schizophrenia after switching to paliperidone palmitate once-monthly from oral antipsychotics.

Authors:  Nan Li; Yu Feng; Huafei Lu; Shang Li Cai; Jianmin Zhuo; Tianmei Si; Lili Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-03-22       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.